Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

For Generics Industry, Will Larger Firms Mean Weaker Lobbying?

Executive Summary

New CEO Chip Davis wants GPhA sitting at the table in policy debates rather than being on the menu, but industry consolidation means there are fewer dues-paying members to fill the chairs.

Advertisement

Related Content

GPhRMA? Generic Trade Group Picks Up Another Exec From Brand Association
Pricing Transparency Policies Not Suited To Generics, GPhA Argues
PhRMA Embraces Teva Across Brand-Generic Divide
If You Can't Beat 'Em … Hire 'Em? PhRMA Exec Is New GPhA CEO
Biosimilars Forum: How Do You Create A Brand-Generic Coalition? Don’t Talk About Naming
GPhA And Actavis Divorcing: Biosimilars Behind The Rift

Topics

Related Companies

Related Deals

What to read next

Advertisement
UsernamePublicRestriction

Register

PS057534

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel